ÂÜÀòÂÒÂ×

Kia Parssanedjad, M.D. is a seasoned executive in the healthcare sector with extensive experience in financial and corporate investment leadership. Currently serving as Chief Financial Officer and Chief Corporate Investment Officer at CHEPLAPHARM since 2021, Kia previously co-led McKinsey & Company's Leap in Healthcare practice from 2018 to 2021. Additional roles include Head of the Digital Office at Merck Group in 2017-2018 and various positions, including Principal and Advisor for Healthcare Private Equity, at TVM Capital Group from 2007 to 2013. Earlier in the career, Kia worked as an Engagement Manager at McKinsey & Company from 2003 to 2007. Education includes a Doctor of Medicine degree from the University of Duisburg-Essen and studies at Harvard Medical School and St Johns Research Institute.